This artificial intelligence infrastructure company reported a notable insider sale after a 40% decline in its share price over the trailing 12 months.
Oilfield services company Patterson-UTI (NASDAQ:PTEN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, but sales were flat year on year at ...
Specialty insurance company Markel Group (NYSE:MKL) beat Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $4.02 billion. ...
Flow control equipment manufacturer Flowserve (NYSE:FLS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, but sales fell by 1.6% year on ye...
FinWise Bancorp (NASDAQ:FINW) reported second-quarter 2026 net income of $2.1 million, or $0.15 per diluted share, as higher loan originations and net interest income were partly offset by increased provisions for credit losses in its traditional banking portfolio.
Chief Executive Officer Jim Noone
FormFactor (NASDAQ:FORM) reported record second-quarter revenue, gross profit and earnings per share, as demand for semiconductor test products increased across high-bandwidth memory, data-center computing and co-packaged optics.
Chief Executive Officer Mike Slessor said the company surpassed a $1
PC Connection (NASDAQ:CNXN) reported record second-quarter results as demand for endpoint devices, software, networking and AI-ready infrastructure lifted sales and profitability, while management said elevated backlog and solid July activity support continued momentum into the third quarter.
For t
Corcept Therapeutics (NASDAQ:CORT) reported second-quarter 2026 revenue of $256.1 million, up 32% from the prior-year period, as sales from its Cushing’s syndrome franchise increased and its newly launched ovarian cancer therapy LIFYORLI contributed $47.6 million in its first quarter of availability
Beta Bionics (NASDAQ:BBNX) reported second-quarter 2026 net sales of $32 million, up approximately 38% from a year earlier, as new patient starts and recurring pharmacy-channel supply revenue supported growth for its iLet insulin-delivery system.
Chief Executive Officer Sean Saint said the company’
DMC Global (NASDAQ:BOOM) reported second-quarter consolidated sales of $157 million, at the high end of its forecast range, while adjusted EBITDA attributable to the company reached $10.7 million and exceeded the high end of guidance. President and CEO James O’Leary said the results reflected progre
Adaptive Biotechnologies (NASDAQ:ADPT) reported second-quarter results marked by accelerating growth in its minimal residual disease, or MRD, business, improved margins and an increased full-year revenue outlook. The company also outlined further steps toward separating its Immune Medicine operation
Align Technology (NASDAQ:ALGN) reported record second-quarter revenue of $1.06 billion, up 4.3% from a year earlier, as record clear aligner volumes and higher revenue in that business offset continued weakness in its systems and services segment.
Chief Executive Officer Joe Hogan said second-quart
Alkami Technology (NASDAQ:ALKT) reported second-quarter revenue and adjusted EBITDA above its expectations, while raising visibility around a full-year outlook that would bring the company close to a five-year financial goal established in 2022.
Chief Executive Officer Alex Shootman said the compan
Regional banking company Stock Yards Bancorp (NASDAQ:SYBT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 17.2% year on year to $114.7 m...
Electronic system and device provider Bel Fuse (NASDAQ:BELFA) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 25.2% year on ...
Commercial real estate lender Franklin BSP Realty Trust (NYSE:FBRT) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 17.1% year o...
Aerospace and defense company Woodward (NASDAQ:WWD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 21.2% year on year to $1.11 billion. I...
